CareDx (CDNA) Tops Q2 EPS by 9c

CareDx (NASDAQ: CDNA) reported Q2 EPS of $0.11, $0.09 better than the analyst estimate of $0.02. Revenue for the quarter came in at $74.2 million versus the consensus estimate of $67.55 million.

GUIDANCE:

CareDx sees FY2021 revenue of $280-290 million, versus the consensus of $278.4 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• CareDx, Inc (CDNA) PT Raised to $45 at BTIG
• CareDx to Report Second Quarter 2026 Financial Results on July 30, 2026
• General Aerospace (GE) Tops Q2 EPS by 16c, Beats on Revenue; Offers FY26 EPS Guidance